Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical examiners and coroners, forensic and clinical laboratory personnel, and all other related communities about new information surrounding the emergent synthetic opioid etodesnitazene.
Tags: Etodesnitazene New Drug Trends Opioid Crisis Safety Alert Trend ReportsEtodesnitazene — New Synthetic Opioid Identified During Forensic Death Investigations in the United States and Canada
-
WV: Announcement of Newly Identified Novel Psychoactive Substance (NPS) in the United States.
Lisa McElhaney / / / Research & Publications
N-Pyrrolidino Etonitazene has been identified in one case in May 2021. The geographical and demographical breakdown is below: Geographical...
-
2021 European Drug Report – Trends and Developments (EMCDDA)
Lisa McElhaney / / / Research & Publications
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released its 2021 drug report this week. Using data...
-
New Benzodiazepines in Europe – a Review
Lisa McElhaney / / / Research & Publications
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released an update on benzodiazepines this week. As of February...
-
NFLIS – 2020 Annual Report – Utilizing DEA Synth-Opioids
Lisa McElhaney / / / Research & Publications
The Drug Enforcement Administration’s (DEA’s) Real-Time Communication Synth-Opioids Network (Synth-Opioids) is designed to create opportunities for swift information exchange...
-
New Synthetic Opioid Protonitazene Increasing in Prevalence as “Nitazenes” Gain Traction Across the United States and Canada
Lisa McElhaney / / / Research & Publications
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
-
CA: Rapid Street Reporting Survey Report: San Francisco Bay Area November 12-14, 2021
Lisa McElhaney / / / Research & Publications
The NDEWS team has launched the Rapid Street Reporting (RSR) study, with the first weekend visit occurring November 12-14...
-
Adverse Effects Linked to Next Generation Opioids Reported in Patients Presenting to Emergency Departments After Suspected Opioid Overdose
Lisa McElhaney / / / Research & Publications
Purpose: The objective of this announcement is to notify public health and safety, clinicians, law enforcement, first responders, medical...
-
INT: Afghanistan’s ‘tablet K’ – a forensic insight into an emerging synthetic drug market
Lisa McElhaney / / / Research & Publications
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
Membership Account
Latest NADDI News
- TX: Court Prohibits Two Texas Physicians from Prescribing Opioids and Imposes $1.2M in Civil Penalties for Alleged Unlawful Opioid Distribution October 10, 2024
- LA: Alleged drug dealer arrested with 600 lethal doses of fentanyl, $4K in cash after investigation into fatal overdose October 8, 2024
- Ten Pharmaceutical Distributor Executives, Sales Representatives, and Brokers Charged in Connection with Unlawful Sales of Nearly 70M Opioid Pills October 3, 2024